Reply

Affiliations

¹ Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery; Weill Cornell Medicine, New York, NY, USA.
² Vascular Medicine Division and National Reference Center for Autoimmune and Autoinflammatory Rare Diseases, Université de Lorraine, Inserm, Défaillance Cardio-Vasculaire Aigüe et Chronique (DCAC), and Centre Hospitalier Régional Universitaire (CHRU)-Nancy, F-54000, Nancy, France.
³ Department of General Medicine and Rheumatology, Middlemore Hospital, Auckland, New Zealand.
⁴ Clinical Investigation Center (CIC) Clinical epidemiology, Centre Hospitalier Régional Universitaire (CHRU), Nancy, Inserm, Université de Lorraine, Nancy, France.
⁵ Department of Rheumatology, Brigham and Women's Hospital, Boston, MA, USA.

Medha Barbhaiya et al. Arthritis Rheumatol. 2024 May.

. 2024 May;76(5):817-818.

doi: 10.1002/art.42794. Epub 2024 Feb 20.

¹ Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery; Weill Cornell Medicine, New York, NY, USA.
² Vascular Medicine Division and National Reference Center for Autoimmune and Autoinflammatory Rare Diseases, Université de Lorraine, Inserm, Défaillance Cardio-Vasculaire Aigüe et Chronique (DCAC), and Centre Hospitalier Régional Universitaire (CHRU)-Nancy, F-54000, Nancy, France.
³ Department of General Medicine and Rheumatology, Middlemore Hospital, Auckland, New Zealand.
⁴ Clinical Investigation Center (CIC) Clinical epidemiology, Centre Hospitalier Régional Universitaire (CHRU), Nancy, Inserm, Université de Lorraine, Nancy, France.
⁵ Department of Rheumatology, Brigham and Women's Hospital, Boston, MA, USA.

No abstract available

References

1. Alijotas‐Reig, Marques‐Soares J, Belizna C, et al. Correspondence and comments on American College of Rheumatology and EULAR antiphospholipid syndrome classification criteria: comment on the article by Barbhaiya et al. Arthritis Rheumatol 2024;76:816–817. doi:10.1002/art.42792
1. Barbhaiya M, Zuily S, Naden R, et al. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol 2023;75:1687–1702.
1. Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis 2023;82:1258–1270.
1. Kelchtermans H, Pelkmans L, de Laat B, et al. IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis. J Thromb Haemost 2016;14:1530–1548.
1. Chayoua W, Kelchtermans H, Gris JC, et al. The (non‐)sense of detecting anti‐cardiolipin and anti‐β2glycoprotein I IgM antibodies in the antiphospholipid syndrome. J Thromb Haemost 2020;18:169–179.